Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 10

    1.

    Rituximab in the treatment of thyroid eye disease: science fiction?

    Salvi M, Vannucchi G, Campi I, Beck-Peccoz P.

    Orbit. 2009;28(4):251-5.PMID: 19839884 [PubMed - in process]Related articles

    2.

    Graves' orbitopathy activation after radioactive iodine therapy with and without steroid prophylaxis.

    Vannucchi G, Campi I, Covelli D, Dazzi D, Currò N, Simonetta S, Ratiglia R, Beck-Peccoz P, Salvi M.

    J Clin Endocrinol Metab. 2009 Sep;94(9):3381-6. Epub 2009 Jun 30.PMID: 19567525 [PubMed - indexed for MEDLINE]Related articles

    3.

    Impact of resistance to thyroid hormone on the cardiovascular system in adults.

    Pulcrano M, Palmieri EA, Mannavola D, Ciulla M, Campi I, Covelli D, Lombardi G, Biondi B, Beck-Peccoz P.

    J Clin Endocrinol Metab. 2009 Aug;94(8):2812-6. Epub 2009 May 12.PMID: 19435825 [PubMed - indexed for MEDLINE]Related articles

    4.

    Rituximab treatment in a patient with severe thyroid-associated ophthalmopathy: effects on orbital lymphocytic infiltrates.

    Salvi M, Vannucchi G, Campi I, Currò N, Simonetta S, Covelli D, Pignataro L, Guastella C, Rossi S, Bonara P, Dazzi D, Ratiglia R, Beck-Peccoz P.

    Clin Immunol. 2009 May;131(2):360-5. Epub 2009 Feb 4.PMID: 19195932 [PubMed - indexed for MEDLINE]Related articles

    5.

    New immunomodulators in the treatment of Graves' ophthalmopathy.

    Salvi M, Vannucchi G, Campi I, Currò N, Beck-Peccoz P.

    Ann Endocrinol (Paris). 2008 Apr;69(2):153-6. Epub 2008 Apr 15.PMID: 18417090 [PubMed - indexed for MEDLINE]Related articles

    6.

    Rituximab induces distinct intraorbital and intrathyroidal effects in one patient satisfactorily treated for Graves' ophthalmopathy.

    Bonara P, Vannucchi G, Campi I, Rossi S, Cantoni F, Frugoni C, Sbrozzi F, Guastella C, Avignone S, Beck-Peccoz P, Salvi M.

    Clin Rev Allergy Immunol. 2008 Feb;34(1):118-23.PMID: 18270865 [PubMed - indexed for MEDLINE]Related articles

    7.

    Treatment of Graves' disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study.

    Salvi M, Vannucchi G, Campi I, Currò N, Dazzi D, Simonetta S, Bonara P, Rossi S, Sina C, Guastella C, Ratiglia R, Beck-Peccoz P.

    Eur J Endocrinol. 2007 Jan;156(1):33-40.PMID: 17218723 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Syndromes of hormone resistance in the hypothalamic-pituitary-thyroid axis.

    Beck-Peccoz P, Persani L, Calebiro D, Bonomi M, Mannavola D, Campi I.

    Best Pract Res Clin Endocrinol Metab. 2006 Dec;20(4):529-46. Review.PMID: 17161330 [PubMed - indexed for MEDLINE]Related articles

    9.

    TBG deficiency: description of two novel mutations associated with complete TBG deficiency and review of the literature.

    Mannavola D, Vannucchi G, Fugazzola L, Cirello V, Campi I, Radetti G, Persani L, Refetoff S, Beck-Peccoz P.

    J Mol Med. 2006 Oct;84(10):864-71. Epub 2006 Sep 1. Review.PMID: 16947003 [PubMed - indexed for MEDLINE]Related articles

    10.

    Efficacy of rituximab treatment for thyroid-associated ophthalmopathy as a result of intraorbital B-cell depletion in one patient unresponsive to steroid immunosuppression.

    Salvi M, Vannucchi G, Campi I, Rossi S, Bonara P, Sbrozzi F, Guastella C, Avignone S, Pirola G, Ratiglia R, Beck-Peccoz P.

    Eur J Endocrinol. 2006 Apr;154(4):511-7.PMID: 16556712 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...